Shandong researchers suggest that edible and medicinal fungi contain bioactive components with therapeutic potential for ...

Protagenic Therapeutics shares soared 240% Monday on its all-stock merger with Phytanix Bio. New Phytanix targets CNS disorders with an expanded diverse pipeline and experienced team.

Scientists discover compounds in medicinal mushrooms that promise to slow Alzheimer's and Parkinson's with fewer serious side ...

Discover the major causes of partial paralysis from stroke and trauma to inflammatory conditions and tumors, plus warning ...

SK Life Science, Inc., a global leader in developing treatments for central nervous system (CNS) disorders and a subsidiary ...

Seasoned biopharma executive brings more than twenty years of business development, strategy, and operational expertise to ...

Neurological disorders, including neurosurgical conditions and various neurological diseases, are often associated with ...

Scientists at Harvard University are proposing a fundamental change in the way we consider psychedelics and their therapeutic ...

The development of drugs to treat major diseases of the central nervous system relies in part on the development of novel strategies to cross the blood brain barrier. Michel Khrestchatisky and ...